A pilot program on the benefits of synthetic psilocybin for mental health issues like post-traumatic stress disorder (PTSD) is set to begin this summer at Yale…
A study published in September in the journal Psychedelic Medicine found a majority of respondents – randomly selected American Psychiatric Association (APA) members – moderately or…
Two landmark clinical trials could pave the way for a new CBD-based medicine to be made available through the NHS for the treatment of chemotherapy-induced peripheral…
Lawmakers in South Dakota on Thursday took a step toward making significant changes to the state’s medical cannabis program. The Republican-controlled state Senate approved a bill…
